Activation of the CHK2-ATM axis mediates G2/M cell cycle arrest [47,48] suggesting niraparib-mediated CHK2 activation as a possible mechanism for the G2/M cell cycle arrest observed in CCA. Here, CHEK2 is linked to cholangiocarcinoma.